Ab Initio Biotherapeutics

Ligand acquires Ab Initio Biotherapeutics, an antigen-discovery company
Pharmaceutical Business Review
Wed, 07/24/19 - 10:20 am
Ligand Pharmaceuticals
Ab Initio Biotherapeutics
M&A